The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

David E. Spaner

Division of Molecular and Cellular Biology

Research Institute S-116A

Sunnybrook and Women's College Health Sciences Center

2075 Bayview Avenue

[email]@*.*.utoronto.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Molecular and Cellular Biology, Research Institute S-116A, Sunnybrook and Women's College Health Sciences Center, 2075 Bayview Avenue. 2002 - 2006
  • Division of Molecular and Cellular Biology, Research Institute, S-116A, Research Building. 2004
  • Department of Medical Biophysics, University of Toronto and Ontario Cancer Institute, Canada. 1998 - 1999
  • Toronto-Sunnybrook Regional Cancer Center, Department of Medicine, University of Toronto, Ontario, Canada. 1998

References

  1. Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells. Spaner, D.E., Shi, Y., White, D., Mena, J., Hammond, C., Tomic, J., He, L., Tomai, M.A., Miller, R.L., Booth, J., Radvanyi, L. Leukemia (2006) [Pubmed]
  2. Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100. Spaner, D.E., Astsaturov, I., Vogel, T., Petrella, T., Elias, I., Burdett-Radoux, S., Verma, S., Iscoe, N., Hamilton, P., Berinstein, N.L. Cancer (2006) [Pubmed]
  3. A phase I/II trial of oxidized autologous tumor vaccines during the "watch and wait" phase of chronic lymphocytic leukemia. Spaner, D.E., Hammond, C., Mena, J., Foden, C., Deabreu, A. Cancer Immunol. Immunother. (2005) [Pubmed]
  4. Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod. Spaner, D.E., Miller, R.L., Mena, J., Grossman, L., Sorrenti, V., Shi, Y. Leuk. Lymphoma (2005) [Pubmed]
  5. Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells. Spaner, D.E. J. Leukoc. Biol. (2004) [Pubmed]
  6. Effect of IL-2R beta-binding cytokines on costimulatory properties of chronic lymphocytic leukaemia cells: implications for immunotherapy. Spaner, D.E., Hammond, C., Mena, J., Shi, Y. Br. J. Haematol. (2004) [Pubmed]
  7. Aberrant regulation of superantigen responses during T-cell reconstitution and graft-versus-host disease in immunodeficient mice. Spaner, D., Sheng-Tanner, X., Schuh, A.C. Blood (2002) [Pubmed]
  8. A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice. Spaner, D., Raju, K., Rabinovich, B., Miller, R.G. J. Immunol. (1999) [Pubmed]
  9. A role for perforin in activation-induced cell death. Spaner, D., Raju, K., Radvanyi, L., Lin, Y., Miller, R.G. J. Immunol. (1998) [Pubmed]
  10. Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient. Spaner, D., Lowsky, R., Fyles, G., Lipton, J.H., Banerjee, D., Ng, C.M., Wade, J.A., Messner, H.A. Transplantation (1998) [Pubmed]
 
WikiGenes - Universities